Skip to main content

Metabolism in the Tumour Microenvironment: Implications for Pathogenesis and Therapeutics

92kviews
Editorial27 January 2026
Editorial: Metabolism in the tumour microenvironment: implications for pathogenesis and therapeutics

The tumour microenvironment (TME) is a heterogeneous composition of stromal, immune 32 cells that respond to local and systemic cues and influence tumour progression and ( de Visser 33 and Joyce, 2023). Preclinical and clinical evidence demonstrate a strong reciprocal relationship between 34 tumour cell oncogenesis and its TME (Klemm and Joyce, 2015). Rather than serving as a passive backdrop, 35the TME functions as a metabolic ecosystem that shapes immunosurveillance, immune evasion and 36 responsiveness to therapy (Zou and Green, 2023). Importantly, the articles featured in this Research Topic 37 converge on a shared principle that metabolic rewiring of the TME is an active driver of immune 38 dysfunction which drives tumour growth and metastasis and contributes to the global health burden of 39 cancer. 40We curated 11 articles that highlight this rapidly advancing frontier, focused on how metabolism reshapes 41 the TME. Collectively, these contributions synthesize mechanistic advances, discuss translational hurdles 42 and outline opportunities for therapeutic advancement that leverage these findings in clinical practice.

1,273 views

MINI REVIEW
16 January 2026
Immunometabolic editing of the tumor microenvironment: from reprogramming mechanisms to therapeutic vulnerabilities
Yixin Li, 2 more and Xueman Chen

3,302 views

10 citations

REVIEW
10 December 2025
Metabolic reprogramming and immune regulation in acute myeloid leukemia
Xiaogang Hao, 9 more and Zhexin Shi

5,628 views

19 citations

ORIGINAL RESEARCH
10 December 2025
RPL41 inhibits the proliferation and migration of retinoblastoma through the ARL5B-associated lysosomal trafficking
Ye Li, 5 more and Yisheng Jiao

2,486 views

REVIEW
16 October 2025
Lactylation and antitumor immunity
Biao Yang, 3 more and Huabao Xiong

9,237 views

25 citations

ORIGINAL RESEARCH
15 August 2025
Linoleic acid drives pulmonary lymphoepithelioma-like carcinoma progression via PPAR-α/TF axis
Hejing Bao, 9 more and Shudong Ma

2,824 views

3 citations

Impact of lactate on immune cell function in the tumor microenvironment: mechanisms and therapeutic perspectives
Lactate has emerged as a key regulator in the tumor microenvironment (TME), influencing both tumor progression and immune dynamics. As a byproduct of aerobic glycolysis, lactate satisfies the metabolic needs of proliferating tumor cells while reshaping the TME to facilitate immune evasion. Elevated lactate levels inhibit effector immune cells such as CD8+ T and natural killer cells, while supporting immunosuppressive cells, such as regulatory T cells and myeloid-derived suppressor cells, thus fostering an immunosuppressive environment. Lactate promotes epigenetic reprogramming, stabilizes hypoxia-inducible factor-1α, and activates nuclear factor kappa B, leading to further immunological dysfunction. In this review, we examined the role of lactate in metabolic reprogramming, immune suppression, and treatment resistance. We also discuss promising therapeutic strategies targeting lactate metabolism, including lactate dehydrogenase inhibitors, monocarboxylate transporter inhibitors, and TME neutralization methods, all of which can restore immune function and enhance immunotherapy outcomes. By highlighting recent advances, this review provides a theoretical foundation for integrating lactate-targeted therapies into clinical practice. We also highlight the potential synergy between these therapies and current immunotherapeutic strategies, providing new avenues for addressing TME-related challenges and improving outcomes for patients with cancer.

20,402 views

200 citations

REVIEW
10 April 2025
Glutamine’s double-edged sword: fueling tumor growth and offering therapeutic hope
Liguang Fang, 3 more and Ming Li

13,475 views

17 citations

ORIGINAL RESEARCH
13 March 2025
Fatty acid metabolism-derived prognostic model for lung adenocarcinoma: unraveling the link to survival and immune response
Rui-Ze Wu, 7 more and Xin Rui

4,100 views

13 citations

REVIEW
13 February 2025
Targeting amino acid metabolism to inhibit gastric cancer progression and promote anti-tumor immunity: a review
Yuchun Jiang, 10 more and Xiaoqin Li

6,943 views

22 citations

ORIGINAL RESEARCH
23 December 2024
SQLE-mediated squalene metabolism promotes tumor immune evasion in pancreatic cancer
Junchen Pan, 5 more and Peng Huang

5,212 views

10 citations